%D8%AA%D8%A7%D9%83%D8%B1%D9%88%D9%84%D9%8A%D9%85%D8%B3%D8%AA%D8%A7%DA%A9%D8%B1%D9%88%D9%84%DB%8C%D9%85%D9%88%D8%B3TakrolimusTacrolimwsTacrolimusTacrolimusTacrolimus%D8%AA%D8%A7%DA%A9%D8%B1%D9%88%D9%84%DB%8C%D9%85%D9%88%D8%B3TakrolimuusiTacrolimus%D7%98%D7%A7%D7%A8%D7%95%D7%9C%D7%99%D7%9E%D7%95%D7%A1TakrolimuszTakrolimusTacrolimus%E3%82%BF%E3%82%AF%E3%83%AD%E3%83%AA%E3%83%A0%E3%82%B9%D0%A2%D0%B0%D0%BA%D1%80%D0%BE%D0%BB%D0%B8%D0%BC%D1%83%D1%81TacrolimusTakrolimusTacrolimo%D0%A2%D0%B0%D0%BA%D1%80%D0%BE%D0%BB%D0%B8%D0%BC%D1%83%D1%81TakrolimusTakrolimusTakrolimusTakrolimus%D0%A2%D0%B0%D0%BA%D1%80%D0%BE%D0%BB%D1%96%D0%BC%D1%83%D1%81TacrolimusQ411648
about
sameAs
The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver TransplantationComparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney TransplantationStudy to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a TransplantBelatacept in Kidney Transplantation of Moderately Sensitized PatientsQuality of Life Questionnaire Validation for Patients With Changed Tacrolimus Dosing After Kidney TransplantationCD40-L Blockade for Prevention of Acute Graft-Versus-Host DiseaseComparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control TrialComparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell TransplantationMitra v Fingerprick Tacrolimus CreatinineConversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal TransplantPK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant PatientsTacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis PatientsAddition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell TransplantTacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant PatientsEfficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney TransplantationA Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on TacrolimusBeclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic CancerReduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine InhibitorsA Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney TransplantationStudy Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft RecipientResearch Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell TransplantationPhase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative StudyA Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched RelativeUmbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseClofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other DiseaseAllogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based RegimenReduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseIslet Allotransplantation With Steroid Free ImmunosuppressionCyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic SyndromeReduction or Discontinuation of CNI's With Conversion to Everolimus-Based ImmunosuppresionStudy of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid WithdrawalSingle Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant RecipientsEfficacy and Safety of Pimecrolimus for the Treatment of Vitiligo VulgarisComparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus NephritisStudy Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant RecipientsBortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell TransplantationA Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant RecipientsEvaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic DermatitisReconstitution With Pimecrolimus Cream 1% of Steroid-damaged Skin in Adults With Atopic Dermatitis
P4844
Q1153419-1E83A7E4-19D3-45C5-B118-54BC64962353Q1194520-DFBF9875-067F-44B2-86B6-E5B674B7D3ABQ1472-8BEA8F6B-B541-45A4-B17A-537125BAB898Q1477-7AA1D0DA-579D-44D2-8828-9293B9845ABFQ1621830-65F6CE94-62E6-423B-BF3E-21F554786B8DQ167844-386523BA-4958-4B64-953E-D7FEB7E791E2Q268667-FA75D206-254F-47F0-A5DD-59D33C366151Q504790-22861540-019F-4C5B-95F4-CBA13BB129ECQ56014460-1E18A3E1-0DFD-4711-B19A-2434063A6BD2Q786844-CDA3FA37-280F-449D-8809-A0C5F0C0D13FQ8285-53359D6D-8F5B-45C4-83E0-E948097C6FEBQ848371-45B3C829-1CA0-4605-A25B-2B4B7E526EC9Q980926-C9DB7ABF-983C-49F9-99D9-0087F996D674
P2176
Q61713181-F56B0D8C-7CF3-4198-8A67-AF88BCE7D84FQ61729741-ED4B362D-BAE2-4D88-8A8F-EB1DD7049104Q61864747-04FEA278-EF1A-467F-B2CE-FC466C1EA82FQ61894370-946BC0A1-1A2E-4F34-BEC5-243B52F535B9Q61902410-AE046693-803D-436C-A93B-13F9CAB0637CQ61907272-8EF809C2-D1B5-46AD-9A3B-320BEFC48B68Q61907473-2D7E0C98-0B7B-4C6A-A400-B1CC45366C46Q61907523-386B44AB-6A9F-48E4-9636-77CDE1672C25Q61907649-B085D745-0551-4A0D-AD46-B724D7CAD151Q61914316-A6E46D19-9C99-4557-87D8-392C7F28DF44Q61914496-2AB55341-280E-4C60-8ADB-CB5F542EE9BCQ61914661-4B303FA8-281D-4CF0-A235-482902156D3FQ61915000-5D24A3E2-4206-4BF2-9962-49805E51324CQ61915267-89309499-0296-4B2F-8750-FF38C0043B01Q61917483-165E3C92-579D-460B-910A-D3436F77AA36Q61917851-E40A26CC-3A64-4D6A-9061-53BCAC2EFD6AQ61917871-EECEE140-F6AC-4DEA-AD01-923289635C3AQ61918165-BD15D742-1C34-44B9-8052-0A0ADE322EAEQ61920566-FB54F825-F617-4349-BCF9-4B4839A38AB2Q61920664-68F84E29-F5A0-47A6-BB11-730AFE8481FDQ61920881-B6D44CD3-BDF6-40A8-BBAE-D8F6D7EEEA14Q61921189-0B41A4A9-0926-4294-9BEA-FBE229C96EE7Q61921193-2B94DB45-10AF-4EC7-8448-486893DC8B67Q61921213-984229CB-8392-4D22-B8B7-25AB27B9EBC6Q61921654-094EDFBE-3392-4F58-BB0A-2E0D1ACEA878Q61921685-F81AC2F3-36F8-49A8-A6AC-E3AC44176205Q61923784-E4B00D67-EDD7-4039-BC8C-CEF2A90714D0Q61924131-73B2EE5D-9EDF-4DAA-9979-C82C8A9B4B25Q61924453-32A45D74-1899-43B5-8B1E-779FD3424394Q61924544-29E50EB5-2CE7-4F94-B08A-4FECDE21EB6BQ61924862-1FEB7B2E-DD5D-4026-A4C0-C55D7D128FB8Q61932472-C344801A-AFFB-430E-BC0A-402044017004Q61932612-143CF291-2A7A-4A7C-B0EB-7E01C34DB2D8Q61933009-C073115D-A1A1-4288-A170-85B6E1B5FFDFQ61933176-9575D3A1-D8B4-4BB7-9062-246B9958E23BQ61933558-AE354779-4C87-407E-8A30-5FD2EA187B45Q61933581-DA21551E-A952-47FC-BC8D-B05FBD1989A9Q61933594-94E4540C-2F43-4F5E-9B90-3A1C4B35E51EQ61933667-56A715DD-56F0-45FC-A75A-B15D2AB4EE3FQ61933902-DCDDB623-9597-4B8E-AA26-CBA394075CF6
P4844
description
chemesch Verbindung
@lb
chemical compound
@en
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
name
Tacrolimus
@cs
Tacrolimus
@de
Tacrolimus
@es
Tacrolimus
@nl
Tacrolimus
@vi
Takrolimus
@id
Takrolimus
@sh
Takrolimus
@sr
Takrolimus
@sv
Takrolimus
@tr
type
label
Tacrolimus
@cs
Tacrolimus
@de
Tacrolimus
@es
Tacrolimus
@nl
Tacrolimus
@vi
Takrolimus
@id
Takrolimus
@sh
Takrolimus
@sr
Takrolimus
@sv
Takrolimus
@tr
altLabel
(-)-FK 506
@cy
(-)-FK 506
@en
104987-11-3
@fr
Anhydrous tacrolimus
@en
C44H69NO12
@fr
FK-506
@de
FK-506
@it
FK506
@cy
FK506
@de
FK506
@en
prefLabel
Tacrolimus
@cs
Tacrolimus
@de
Tacrolimus
@es
Tacrolimus
@nl
Tacrolimus
@vi
Takrolimus
@id
Takrolimus
@sh
Takrolimus
@sr
Takrolimus
@sv
Takrolimus
@tr